Figure 3.
Figure 3. Evidence of eNOS expression in RBCs. (A) Western blot analysis revealed an eNOS-specific band at 140 kDa in preparations of RBCs (lanes 2 and 3 are derived from diluted preparations [Hct 20%, 10%, and 5%, respectively; with 15, 7.5, and 3.8 μg protein/lane]). This band is equivalent to positive controls of human aortic endothelial cells (HAECs; 2 μg protein/line) and myocardium (cell lysate; 1 μg protein/line). (B) The 450-bp fragment of eNOS mRNA from RBCs corresponds to the control of HUVECs and whole blood. The purity of the RBC fraction was confirmed by mRNA amplification of reference proteins: endoglin for HUVECs, β-globin for RBCs, β-3 integrin for platelets, and CD45 for WBCs. Whole blood was taken as positive control.

Evidence of eNOS expression in RBCs. (A) Western blot analysis revealed an eNOS-specific band at 140 kDa in preparations of RBCs (lanes 2 and 3 are derived from diluted preparations [Hct 20%, 10%, and 5%, respectively; with 15, 7.5, and 3.8 μg protein/lane]). This band is equivalent to positive controls of human aortic endothelial cells (HAECs; 2 μg protein/line) and myocardium (cell lysate; 1 μg protein/line). (B) The 450-bp fragment of eNOS mRNA from RBCs corresponds to the control of HUVECs and whole blood. The purity of the RBC fraction was confirmed by mRNA amplification of reference proteins: endoglin for HUVECs, β-globin for RBCs, β-3 integrin for platelets, and CD45 for WBCs. Whole blood was taken as positive control.

Close Modal

or Create an Account

Close Modal
Close Modal